{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:08:16Z","timestamp":1768734496877,"version":"3.49.0"},"reference-count":42,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,30]]},"DOI":"10.20945\/2359-3997000000395","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T20:45:43Z","timestamp":1633034743000},"source":"Crossref","is-referenced-by-count":2,"title":["Growth hormone-releasing hormone-secreting pulmonary neuroendocrine tumor associated with pituitary hyperplasia and somatotropinoma"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6026-4329","authenticated-orcid":false,"given":"Elisa B.","family":"Lamback","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9514-0986","authenticated-orcid":false,"given":"Daniel G.","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7256-8111","authenticated-orcid":false,"given":"Mari C.","family":"Vazquez-Borrego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2299-4814","authenticated-orcid":false,"given":"Carlos H. de Azeredo","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-3192","authenticated-orcid":false,"given":"Leandro","family":"Kasuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-1913","authenticated-orcid":false,"given":"Raul M.","family":"Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6059-0872","authenticated-orcid":false,"given":"Leila","family":"Chimelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9250-3558","authenticated-orcid":false,"given":"M\u00f4nica R.","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8510","reference":[{"issue":"1","key":"key20210930163918_B1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ecl.2007.10.002","article-title":"Acromegaly","volume":"37","author":"Ben-Shlomo","year":"2008","unstructured":"1. Ben-Shlomo A, Melmed S. Acromegaly. Endocrinol Metab Clin North Am. 2008;37(1):101-22, viii.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"key20210930163918_B2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ando.2012.09.004","article-title":"Acromegaly induced by ectopic secretion of GHRH: A review 30 years after GHRH discovery","volume":"73","author":"Borson-Chazot","year":"2012","unstructured":"2. Borson-Chazot F, Garby L, Raverot G, Claustrat F, Raverot V, Sassolas G. Acromegaly induced by ectopic secretion of GHRH: A review 30 years after GHRH discovery. Ann Endocrinol (Paris). 2012;73(6):497-502.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"9","key":"key20210930163918_B3","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1023\/A:1012272314550","article-title":"Epidemiology and survival in patients with carcinoid disease in the Netherlands. An epidemiological study with 2391 patients","volume":"12","author":"Quaedvlieg","year":"2001","unstructured":"3. Quaedvlieg PFHJ, Visser O, Lamers CBHW, Janssen-Heijen MLG, Taal BG. Epidemiology and survival in patients with carcinoid disease in the Netherlands. An epidemiological study with 2391 patients. Ann Oncol. 2001;12(9):1295-300.","journal-title":"Ann Oncol"},{"issue":"4","key":"key20210930163918_B4","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","unstructured":"4. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934-59.","journal-title":"Cancer"},{"issue":"3","key":"key20210930163918_B5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11102-007-0045-7","article-title":"Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients","volume":"10","author":"Biermasz","year":"2007","unstructured":"5. Biermasz NR, Smit JWA, Pereira AM, Fr\u00f6lich M, Romijn JA, Roelfsema F. Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients. Pituitary. 2007;10(3):237-49.","journal-title":"Pituitary"},{"issue":"5","key":"key20210930163918_B6","doi-asserted-by":"crossref","DOI":"10.1097\/01.ten.0000089860.69958.83","article-title":"Acromegaly Secondary to Ectopic Growth Hormone-Releasing Hormone-Secreting Bronchial Carcinoid Cured After Pneumectomy","volume":"13","author":"Reuters","year":"2003","unstructured":"6. Reuters VS, Dias EMR, Pupo MRSR, Gadelha MR. Acromegaly Secondary to Ectopic Growth Hormone-Releasing Hormone-Secreting Bronchial Carcinoid Cured After Pneumectomy. Endocrinologist. 2003;13(5).","journal-title":"Endocrinologist"},{"issue":"9","key":"key20210930163918_B7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11864-019-0671-0","article-title":"Carcinoid Syndrome: Updates and Review of Current Therapy","volume":"20","author":"Oleinikov","year":"2019","unstructured":"7. Oleinikov K, Avniel-Polak S, Gross DJ, Grozinsky-Glasberg S. Carcinoid Syndrome: Updates and Review of Current Therapy. Curr Treat Options Oncol. 2019;20(9):70.","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"key20210930163918_B8","first-page":"551","article-title":"MR Height of the Pituitary Gland as a Function of Age and Sex: Especially Physiological Hypertrophy in Adolescence and in Climacterium","volume":"18","author":"Tsunoda","year":"1997","unstructured":"8. Tsunoda A, Okuda O, Sato K. MR Height of the Pituitary Gland as a Function of Age and Sex: Especially Physiological Hypertrophy in Adolescence and in Climacterium. AJNR Am J Neuroradiol. 1997;18(3):551-4.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"key20210930163918_B9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12020-020-02402-5","article-title":"Cyclin A in nonfunctioning pituitary adenomas","volume":"70","author":"Lamback","year":"2020","unstructured":"9. Lamback EB, Guterres A, Barbosa MA, Lima CHA, Silva DA, Camacho AHDS, et al. Cyclin A in nonfunctioning pituitary adenomas. Endocrine. 2020;70(2):380-7.","journal-title":"Endocrine"},{"issue":"4","key":"key20210930163918_B10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1158\/1078-0432.CCR-19-2154","article-title":"A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors","volume":"26","author":"V\u00e1zquez-Borrego","year":"2020","unstructured":"10. V\u00e1zquez-Borrego MC, Gupta V, Ib\u00e1\u00f1ez-Costa A, Gahete MD, Venegas-Moreno E, Toledano-Delgado \u00c1, et al. A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors. Clin Cancer Res. 2020;26(4):957-69.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"key20210930163918_B11","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1210\/jc.2011-2930","article-title":"Clinical characteristics and outcome of acromegaly induced by ectopic secretion of Growth Hormone-Releasing Hormone (GHRH): A French nationwide series of 21 cases","volume":"97","author":"Garby","year":"2012","unstructured":"11. Garby L, Caron P, Claustrat F, Chanson P, Tabarin A, Rohmer V, et al. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of Growth Hormone-Releasing Hormone (GHRH): A French nationwide series of 21 cases. J Clin Endocrinol Metab. 2012;97(6):2093-104.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key20210930163918_B12","first-page":"263","article-title":"Acromegaly caused by a growth hormone-releasing hormone secreting carcinoid tumour of the lung: the effect of octreotide treatment","volume":"65","author":"de Jager","year":"2007","unstructured":"12. de Jager CM, de Heide LJ, van den Berg G, Wolthuis A, van Schelven WD. Acromegaly caused by a growth hormone-releasing hormone secreting carcinoid tumour of the lung: the effect of octreotide treatment. Neth J Med. 2007;65(7):263-6.","journal-title":"Neth J Med"},{"issue":"12","key":"key20210930163918_B13","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2006-0610","article-title":"Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma","volume":"91","author":"Nasr","year":"2006","unstructured":"13. Nasr C, Mason A, Mayberg M, Staugaitis SM, Asa SL. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma. J Clin Endocrinol Metab. 2006;91(12):4776-80.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20210930163918_B14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(17)30110-9","article-title":"Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study","volume":"18","author":"Halperin","year":"2017","unstructured":"14. Halperin DM, Shen C, Dasari A, Xu Y, Chu Y, Zhou S, et al. Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study. Lancet Oncol. 2017;18(4):525-34.","journal-title":"Lancet Oncol"},{"key":"key20210930163918_B15","article-title":"Carcinoid syndrome: update on the pathophysiology and treatment","volume":"73","author":"Rubin de Celis Ferrari","year":"2018","unstructured":"15. Rubin de Celis Ferrari AC, Glasberg J, Riechelmann RP. Carcinoid syndrome: update on the pathophysiology and treatment. Clinics (Sao Paulo). 2018;73(Suppl 1):e490s.","journal-title":"Clinics"},{"issue":"10","key":"key20210930163918_B16","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","unstructured":"16. Alrezk R, Hannah-Shmouni F, Stratakis CA. MEN4 and CDKN1B mutations: the latest of the MEN syndromes. Endocr Relat Cancer. 2017;24(10):T195-208.","journal-title":"Endocr Relat Cancer"},{"issue":"1-2","key":"key20210930163918_B17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","unstructured":"17. Thakker RV. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4). Mol Cell Endocrinol. 2014;386(1-2):2-15.","journal-title":"Mol Cell Endocrinol"},{"issue":"13","key":"key20210930163918_B18","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/hmg\/6.13.2285","article-title":"Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung","volume":"6","author":"Debelenko","year":"1997","unstructured":"18. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, et al. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet. 1997;6(13):2285-90.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"key20210930163918_B19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1046\/j.1440-1827.1999.00971.x","article-title":"MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation","volume":"49","author":"Fujii","year":"1999","unstructured":"19. Fujii T, Kawai T, Saito K, Hishima T, Hayashi Y, Imura J, et al. MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation. Pathol Int. 1999;49(11):968-73.","journal-title":"Pathol Int"},{"issue":"2","key":"key20210930163918_B20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9440(10)65289-3","article-title":"Mutations and Allelic Deletions of the MEN1 Gene Are Associated with a Subset of Sporadic Endocrine Pancreatic and Neuroendocrine Tumors and Not Restricted to Foregut Neoplasms","volume":"154","author":"G\u00f6rtz","year":"1999","unstructured":"20. G\u00f6rtz B, Roth J, Kr\u00e4henmann A, de Krijger RR, Muletta-Feurer S, R\u00fctimann K, et al. Mutations and Allelic Deletions of the MEN1 Gene Are Associated with a Subset of Sporadic Endocrine Pancreatic and Neuroendocrine Tumors and Not Restricted to Foregut Neoplasms. Am J Pathol. 1999;154(2):429-36.","journal-title":"Am J Pathol"},{"issue":"11","key":"key20210930163918_B21","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1002\/humu.21354","article-title":"A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization","volume":"31","author":"Molatore","year":"2010","unstructured":"21. Molatore S, Marinoni I, Lee M, Pulz E, Ambrosio MR, degli Uberti EC, et al. A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization. Hum Mutat. 2010;31(11):E1825-35.","journal-title":"Hum Mutat"},{"issue":"5","key":"key20210930163918_B22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1210\/jcem-63-5-1057","article-title":"Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion","volume":"63","author":"Barkan","year":"1986","unstructured":"22. Barkan AL, Shenker Y, Grekin RJ, Vale WW, Lloyd RV, Beals TF. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. J Clin Endocrinol Metab. 1986;63(5):1057-64.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20210930163918_B23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jtcvs.2004.02.033","article-title":"Acromegaly caused by ectopic growth hormone-releasing hormone secretion by a carcinoid bronchial tumor: A rare entity","volume":"128","author":"Athanassiadi","year":"2004","unstructured":"23. Athanassiadi K, Exarchos D, Tsagarakis S, Bellenis I. Acromegaly caused by ectopic growth hormone-releasing hormone secretion by a carcinoid bronchial tumor: A rare entity. J Thorac Cardiovasc Surg. 2004;128(4):631-2.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"key20210930163918_B24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/jcem-48-1-66","article-title":"Acromegaly Associated with a Bronchial Carcinoid Tumor: Evidence for Ectopic Production of Growth Hormone-Releasing Activity","volume":"48","author":"Saeed uz Zafar","year":"1979","unstructured":"24. Saeed uz Zafar M, Mellinger RC, Fine G, Szabo M, Frohman LA. Acromegaly Associated with a Bronchial Carcinoid Tumor: Evidence for Ectopic Production of Growth Hormone-Releasing Activity. J Clin Endocrinol Metab. 1979;48(1):66-71.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20210930163918_B25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary Apoplexy","volume":"36","author":"Briet","year":"2015","unstructured":"25. Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P. Pituitary Apoplexy. Endocr Rev. 2015;36(6):622-45.","journal-title":"Endocr Rev"},{"issue":"7","key":"key20210930163918_B26","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/archinte.161.7.1010","article-title":"Pituitary Gangliocytoma-Adenoma Presenting with Acromegaly: Response to Treatment","volume":"161","author":"Luna","year":"2001","unstructured":"26. Luna V, Morales F, Luengo LM, Sanz A, Diaz J. Pituitary Gangliocytoma-Adenoma Presenting with Acromegaly: Response to Treatment. Arch Intern Med. 2001;161(7):1010-1.","journal-title":"Arch Intern Med"},{"issue":"3","key":"key20210930163918_B27","first-page":"611","article-title":"Intrasellar Pituitary Gangliocyto-Adenoma Presenting with Acromegaly: Case Report","volume":"40","author":"Morikawa","year":"1997","unstructured":"27. Morikawa M, Tamaki N, Kokunai T, Imai Y. Intrasellar Pituitary Gangliocyto-Adenoma Presenting with Acromegaly: Case Report. Neurosurgery. 1997;40(3):611-4; discussion 614-5.","journal-title":"Neurosurgery"},{"issue":"3","key":"key20210930163918_B28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3181\/00379727-193-3-RC1","article-title":"Pituitary Mammosomatotroph Adenomas Develop in Old Mice Transgenic for Growth Hormone-Releasing Hormone","volume":"193","author":"Asa","year":"1990","unstructured":"28. Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzalez-Manchon C, et al. Pituitary Mammosomatotroph Adenomas Develop in Old Mice Transgenic for Growth Hormone-Releasing Hormone. Proc Soc Exp Biol Med. 1990;193(3):232-5.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"5","key":"key20210930163918_B29","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1210\/endo-125-5-2710","article-title":"Adenohypophysial Changes in Mice Transgenic for Human Growth Hormone-Releasing Factor: A Histological, Immunocytochemical, and Electron Microscopic Investigation","volume":"125","author":"Stefaneanu","year":"1989","unstructured":"29. Stefaneanu L, Kovacs K, Horvath E, Asa SL, Losinski NE, Billestrup N, et al. Adenohypophysial Changes in Mice Transgenic for Human Growth Hormone-Releasing Factor: A Histological, Immunocytochemical, and Electron Microscopic Investigation. Endocrinology. 1989;125(5):2710-8.","journal-title":"Endocrinology"},{"issue":"18","key":"key20210930163918_B30","doi-asserted-by":"crossref","first-page":"6854","DOI":"10.1073\/pnas.83.18.6854","article-title":"Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro","volume":"83","author":"Billestrup","year":"1986","unstructured":"30. Billestrup N, Swanson LW, Vale W. Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci U S A. 1986;83(18):6854-7.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"key20210930163918_B31","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1210\/endo.142.9.8382","article-title":"The Effect of GHRH on Somatotrope Hyperplasia and Tumor Formation in the Presence and Absence of GH Signaling","volume":"142","author":"Kineman","year":"2001","unstructured":"31. Kineman RD, Teixeira LT, Amargo GV, Coschigano KT, Kopchick JJ, Frohman LA. The Effect of GHRH on Somatotrope Hyperplasia and Tumor Formation in the Presence and Absence of GH Signaling. Endocrinology. 2001;142(9):3764-73.","journal-title":"Endocrinology"},{"issue":"7","key":"key20210930163918_B32","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1210\/en.2008-1482","article-title":"Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation","volume":"150","author":"Luque","year":"2009","unstructured":"32. Luque RM, Soares BS, Peng XD, Krishnan S, Cordoba-Chacon J, Frohman LA, et al. Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation. Endocrinology. 2009;150(7):3177-85.","journal-title":"Endocrinology"},{"issue":"2","key":"key20210930163918_B33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/1097-0142(19880715)62:2<445::AID-CNCR2820620233>3.0.CO;2-5","article-title":"Reversible sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in a acromegalic patient with multiple endocrine neoplasia type I syndrome","volume":"62","author":"Ramsay","year":"1988","unstructured":"33. Ramsay JA, Kovacs K, Asa SL, Pike MJ, Thorner MO. Reversible sellar enlargement due to growth hormone-releasing hormone production by pancreatic endocrine tumors in a acromegalic patient with multiple endocrine neoplasia type I syndrome. Cancer. 1988;62(2):445-50.","journal-title":"Cancer"},{"issue":"11","key":"key20210930163918_B34","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20401","article-title":"Mechanisms for pituitary tumorigenesis: the plastic pituitary","volume":"112","author":"Melmed","year":"2003","unstructured":"34. Melmed S. Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest. 2003;112(11):1603-18.","journal-title":"J Clin Invest"},{"issue":"11","key":"key20210930163918_B35","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrc926","article-title":"The pathogenesis of pituitary tumours","volume":"2","author":"Asa","year":"2002","unstructured":"35. Asa SL, Ezzat S. The pathogenesis of pituitary tumours. Nat Rev Cancer. 2002;2(11):836-49.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"key20210930163918_B36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/ERC-11-0059","article-title":"Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation","volume":"18","author":"Villa","year":"2011","unstructured":"36. Villa C, Lagonigro MS, Magri F, Koziak M, Jaffrain-Rea ML, Brauner R, et al. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation. Endocr Relat Cancer. 2011;18(3):347-56.","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"key20210930163918_B37","first-page":"328","article-title":"Brazilian multicenter study on pegvisomant treatment in acromegaly","volume":"63","author":"Boguszewski","year":"2019","unstructured":"37. Boguszewski CL, Huayllas MKP, Vilar L, Naves LA, Ribeiro-Oliveira A, Soares BS, et al. Brazilian multicenter study on pegvisomant treatment in acromegaly. Arch Endocrinol Metab. 2019;63(4):328-336.","journal-title":"Arch Endocrinol Metab"},{"issue":"5","key":"key20210930163918_B38","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1590\/2359-3997000000210","article-title":"Experience with pegvisomant treatment in acromegaly in a single Brazilian tertiary reference center: Efficacy, safety and predictors of response","volume":"60","author":"Kasuki","year":"2016","unstructured":"38. Kasuki L, Machado EO, Ogino LL, Coelho MC, Silva CM, Wildemberg LE, et al. Experience with pegvisomant treatment in acromegaly in a single Brazilian tertiary reference center: Efficacy, safety and predictors of response. Arch Endocrinol Metab. 2016;60(5):479-85.","journal-title":"Arch Endocrinol Metab"},{"issue":"9","key":"key20210930163918_B39","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1210\/jcem.83.9.5088","article-title":"Long-Acting Lanreotide Induces Clinical and Biochemical Remission of Acromegaly Caused by Disseminated Growth Hormone-Releasing Hormone-Secreting Carcinoid","volume":"83","author":"Drange","year":"1998","unstructured":"39. Drange MR, Melmed S. Long-Acting Lanreotide Induces Clinical and Biochemical Remission of Acromegaly Caused by Disseminated Growth Hormone-Releasing Hormone-Secreting Carcinoid. J Clin Endocrinol Metab. 1998;83(9):3104-9.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key20210930163918_B40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00259-015-3190-7","article-title":"Long-term results of PRRT in advanced bronchopulmonary carcinoid","volume":"43","author":"Mariniello","year":"2016","unstructured":"40. Mariniello A, Bodei L, Tinelli C, Baio SM, Gilardi L, Colandrea M, et al. Long-term results of PRRT in advanced bronchopulmonary carcinoid. Eur J Nucl Med Mol Imaging. 2016;43(3):441-52.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"key20210930163918_B41","doi-asserted-by":"crossref","first-page":"12991","DOI":"10.1007\/s13277-016-5258-9","article-title":"Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors","volume":"37","author":"Lo Russo","year":"2016","unstructured":"41. Lo Russo G, Pusceddu S, Prinzi N, Imbimbo M, Proto C, Signorelli D, et al. Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors. Tumour Biol. 2016;37(10):12991-3003.","journal-title":"Tumour Biol"},{"issue":"2","key":"key20210930163918_B42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.17925\/EE.2020.16.2.93","article-title":"High-dose Somatostatin Analogues for Progressive Neuroendocrine Tumours","volume":"16","author":"Sharp","year":"2020","unstructured":"42. Sharp AJ, Hayes AR, Grossman A. High-dose Somatostatin Analogues for Progressive Neuroendocrine Tumours. Eur Endocrinol. 2020;16(2):93-95.","journal-title":"Eur Endocrinol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T20:46:32Z","timestamp":1633034792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aem-sbem.com\/article\/growth-hormone-releasing-hormone-secreting-pulmonary-neuroendocrine-tumor-associated-with-pituitary-hyperplasia-and-somatotropinoma\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":42,"alternative-id":["10.20945\/2359-3997000000395"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000395","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]}}}